Related references
Note: Only part of the references are listed.Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up
J. F. Arevalo et al.
EYE (2009)
Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: A one-year prospective study
Ziad F. Bashshur et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Clinical pharmacokinetics of bevacizumab in patients with solid tumors
Jian-Feng Lu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Intravitreal bevacizumab for myopic choroidal neovascularization
Florian Rensch et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2008)
Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration
Michael S. Ip et al.
OPHTHALMOLOGY (2008)
Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6- and 9-month results
C. A. Cleary et al.
EYE (2008)
Pharmacokinetics of intravitreal ranibizumab (Lucentis)
Sophie J. Bakri et al.
OPHTHALMOLOGY (2007)
Early bevacizumab treatment of central retinal vein occlusion
Daniela C. Ferrara et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
Frank A. Scappaticci et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma
Shahin Yazdani et al.
JOURNAL OF GLAUCOMA (2007)
Pharmacokinetics of intravitreal bevackumab (avastin)
Sophie J. Bakri et al.
OPHTHALMOLOGY (2007)
Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion
Z. Vatavuk et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2007)
Intravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucoma
Milko E. Iliev et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Transscleral drug delivery to the posterior eye: Prospects of pharmacokinetic modeling
Veli-Pekka Ranta et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy
John O. Mason et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
Robert L. Avery et al.
OPHTHALMOLOGY (2006)
Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA study): Results of a phase 1 dose-escalation study
Rogerio A. Costa et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200
B. J. Giantonio et al.
ANNALS OF ONCOLOGY (2006)
Intracameral bevacizumab for iris rubeosis
Salvatore Grisanti et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Regression of retinal and iris neovascularization after intravitreal bevacizumab (avastin) treatment
Robert L. Avery
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Addition of bevacizurnab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: Results of a randomized phase II trial
FF Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
